MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.01.2026 г., 23:29 ч. UTC

Горещи акции

Stocks to Watch: Atossa Therapeutics, Union Pacific

16.01.2026 г., 22:48 ч. UTC

Придобивния, сливания и поглъщания

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- 2nd Update

16.01.2026 г., 22:43 ч. UTC

Придобивния, сливания и поглъщания

Union Pacific: Additional Information Requested to Be Provided to Surface Transportation Board

16.01.2026 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- Update

16.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

16.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Auto & Transport Roundup: Market Talk

16.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

16.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

16.01.2026 г., 21:48 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Union Pacific, Norfolk Southern Market Share Ruled as Faulty -- Market Talk

16.01.2026 г., 21:41 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Union Pacific, Norfolk Southern Deal Rejection Leaves Questions -- Market Talk

16.01.2026 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Rail Regulator Sends $71.5 Billion Union Pacific-Norfolk Southern Deal Back for Redo -- WSJ

16.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

STB: Union Pacific, Norfolk Southern Application Doesn't Include 'Projected Market Shares' as Required

16.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

STB: Union Pacific, Norfolk Southern Application Doesn't Include Certain Schedules, Documents Expressly Made Part of Merger Agreement

16.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

STB: Union Pacific, Norfolk Southern Application Doesn't Contain Certain Information Required by Regulations

16.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

STB: Application Rejected Without Prejudice to Union Pacific, Norfolk Southern Refiling Revised Application Remedying Deficiencies

16.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Surface Transportation Board: Union Pacific, Norfolk Southern Major Merger Application Filed Dec. 19 Incomplete

16.01.2026 г., 20:44 ч. UTC

Печалби

5 Takeaways From This Season's Wealth Management Earnings -- Barrons.com

16.01.2026 г., 20:42 ч. UTC

Пазарно говорене

Oil Futures Post Fourth Straight Weekly Gain -- Market Talk

16.01.2026 г., 20:28 ч. UTC

Пазарно говорене

U.S. Natural Gas Slips Ahead of Long Weekend -- Market Talk

16.01.2026 г., 19:12 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Could Comment on Structure of Warner Bid During 4Q Results -- Market Talk

16.01.2026 г., 18:53 ч. UTC

Пазарно говорене

Global Crude Supply Enough to Absorb Any Iran Disruption -- Market Talk

16.01.2026 г., 18:41 ч. UTC

Пазарно говорене

Netflix's Ad Business Seen as Primary Revenue Driver in 2026 -- Market Talk

16.01.2026 г., 18:31 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 1 to 410 -- Market Talk

16.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

16.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

16.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

16.01.2026 г., 17:03 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

16.01.2026 г., 17:03 ч. UTC

Пазарно говорене

All Eyes on Guidance for European Big Pharma Earnings Season -- Market Talk

16.01.2026 г., 16:32 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Sanofi Needs Dealmaking to Offset Pipeline Disappointments -- Market Talk

16.01.2026 г., 16:20 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.